Comments
Pharma major Dr Reddy’s Laboratories Ltd has launched its pain killer, Nise D spray, in the over the counter (OTC) segment in the Indian market.
In India, the market for pain relief products is worth approximately ₹1,700 crore. Pain relief sprays are growing 20 times faster than creams and gels, indicating a trend of changing consumer preferences.
M V Ramana EVP & Head Branded Markets (India & Emerging countries), Dr Reddy’s said: “Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio. Nise gel has made a remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions.”
Nise D Spray will be available across all leading and neighbourhood pharmacy stores. It will be available in two convenient pack sizes – pocket pack at ₹99 and home pack for ₹130.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.